Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) does not speed up your metabolism in the way a stimulant would. The weight loss it produces comes primarily from a sharp reduction in appetite and slower gastric emptying — not from burning more calories at rest. That said, preserving or increasing lean muscle through adequate protein and activity while taking it can protect your metabolic rate during treatment. As a prescription-only medicine, whether tirzepatide is clinically suitable for you is a decision made by a prescriber after a full assessment, not something that can be determined from a search result alone.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It's one of the most common things people ask after seeing rapid weight loss on social media, does tirzepatide somehow switch your body into a higher gear, burning through energy faster? The short answer is no, not directly. Mounjaro is not a stimulant. It does not raise your heart rate, bump up your body temperature, or tell your cells to torch more fuel at rest. If you've heard it described as a metabolism booster in that sense, that framing overstates what the medicine actually does.
The real picture is more interesting (and more useful) than that. Tirzepatide activates two gut-hormone receptors, GIP and GLP-1, that work together to dampen appetite signals, slow the rate at which food leaves your stomach, and improve how your body handles blood sugar. The result is that you feel full sooner, stay full longer, and eat considerably less without the white-knuckle willpower required by a conventional diet. That reduction in energy intake is the primary engine of the weight loss seen in trials. You can read more about the full range of physiological changes tirzepatide produces on our Mounjaro and metabolism overview.
The distinction matters practically. If you're expecting a faster heartbeat or a noticeable surge in energy the way a strong coffee delivers, you are unlikely to feel that. What most people do notice, fairly quickly, is that finishing a meal feels different, and that the mental noise around food tends to quiet down.
Here is where the metabolic picture gets nuanced. When anyone loses a meaningful amount of weight (through any route) their resting metabolic rate tends to fall. A smaller body simply requires fewer calories to maintain itself. This is sometimes called metabolic adaptation, and it's one reason weight regain can happen when treatment stops and appetite returns to baseline.
Tirzepatide does not appear to make this adaptation worse than other weight-loss methods. Some early research suggests GLP-1 and GIP receptor activation may have modest direct effects on fat tissue and energy regulation, but the NHS's patient guidance on tirzepatide does not characterise the medicine as a metabolic stimulant, and the effect sizes observed in trials are best attributed to reduced calorie intake rather than increased calorie burning. A question many people have is whether Mounjaro slows metabolism, and our dedicated page goes into this in detail, covering how its effects on energy balance compare across different angles. If you'd like to understand more broadly whether Mounjaro helps your metabolism, our page on that topic explores what the evidence actually shows about tirzepatide's metabolic effects beyond weight loss alone.
There is a practical upside, though. Because tirzepatide tends to reduce appetite rather than simply restricting calories artificially, people often find it easier to prioritise protein and vegetables in the meals they do eat, and those choices genuinely do support a healthier metabolic picture over time.
If your goal is to lose fat while keeping as much lean muscle as possible (which is what most people mean when they say they want a faster metabolism) the levers available to you during tirzepatide treatment are straightforward, if not always easy.
Adequate protein intake is the first one. Eating enough protein each day (the exact target depends on your starting weight and activity level, and is best set with a dietitian or your prescriber) reduces the proportion of weight lost that comes from muscle rather than fat. Resistance exercise (lifting, bodyweight work, anything that asks your muscles to push against load) works alongside protein to preserve lean mass and maintain the metabolic rate that goes with it.
Hydration matters too, particularly because the gastrointestinal effects of the medicine can affect appetite for fluids as well as food. A question our prescribers hear regularly is whether specific supplements are needed; the short answer is that this varies by individual and is worth raising at your clinical review rather than self-prescribing from a list.
The SURMOUNT-1 trial, published in the New England Journal of Medicine, reported average weight reductions of around 20–21% at the 15 mg dose over 72 weeks, results achieved alongside a reduced-calorie diet and increased physical activity, not in isolation. That context is easy to lose in headlines, but it's important to the metabolic story. The lifestyle element is not a footnote.
For practical cost context if you're weighing up whether treatment fits your budget, our Mounjaro cost page explains current UK private pricing and what a legitimate prescription should include.
Tirzepatide treatment starts at 2.5 mg, a dose designed to let your body adjust gradually, particularly to the gastrointestinal effects, rather than to produce weight loss in itself. The prescriber then typically increases the dose every four weeks as tolerated, with the intention of reaching the highest dose that suits you individually.
As the dose increases and appetite suppression deepens, calorie intake tends to fall further, and the metabolic adaptation that comes with weight loss becomes a more practical consideration. This is one reason why maintaining activity and protein through the titration period (not just at the start) makes a difference to how your metabolism responds over the course of treatment. It's worth raising the topic with your prescriber rather than waiting until you notice a plateau.
If you're curious how other people have found managing these lifestyle factors alongside their treatment, our Mounjaro experiences page covers common questions and themes from people going through the titration process. The NHS tirzepatide guidance is also a reliable plain-English starting point for understanding what to expect at each stage. Tirzepatide treatment as a whole (its mechanism, licensed uses, and the prescribing process) is covered in full on our tirzepatide overview.
Speak to our prescribers if you'd like a clinical assessment and a clear picture of whether tirzepatide is appropriate for you. Start your free consultation and a GPhC-registered Independent Prescriber will review your details the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.